お問い合わせ

採用情報

 class=

Company Name Nikon CeLL innovation Co. Ltd.
Shareholder Nikon Corporation (100%)
Establishment May 7th, 2015
Head Office Shinagawa Intercity Tower C, 2-15-3, Kounan Minato-Ku, Tokyo 108-6290 Japan
Facility Tokyo Grand Port AKB, 2-4-10 Shinsuna, Koto-Ku, Tokyo 136-0075 Japan
CDMO Service Offering
  • Cell and Gene Therapy Process Development (CDO)
  • Cell and Gene Therapy Manufacturing Service (CMO)
Features

Exclusive Collaboration with Lonza to further development of Cell and Gene Therapy manufacturing in Japan

One of the Largest CDMO facility in Japan (7,500 m²)

Process Development
  • Technology Transfer
  • Process Development/Optimization
  • Assay Development/Optimization
  • Process Scale-up/Scale-out
GCTP / GMP Manufacturing Service
  • Autologous, Allogeneic Cells.
  • Cell Isolation, Expansion and Differentiation
  • Master Cell Bank Production
  • Various Gene Modification Techniques
  • Quality Control
  • Quality Assurance
  • Supply Chain (storage, shipping, and logistics)
  • Regulatory Support
  • GCTP : Good Gene, Cellular, and Tissue-based Products Manufacturing Practice
  • GMP : Good Manufacturing Practice
  • CDMO : Contract Development and Manufacturing Organization